Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2021-08-06 2021-03-29
Drug Identification Number 02242527 02242527
Brand name SANDOZ PROCTOMYXIN HC SANDOZ PROCTOMYXIN HC
Common or Proper name SANDOZ PROCTOMYXIN HC SANDOZ PROCTOMYXIN HC
Company Name ODAN LABORATORIES LTD ODAN LABORATORIES LTD
Ingredients HYDROCORTISONE DIBUCAINE HYDROCHLORIDE FRAMYCETIN SULFATE ESCULIN HYDROCORTISONE DIBUCAINE HYDROCHLORIDE FRAMYCETIN SULFATE ESCULIN
Strength(s) 0.5% 0.5% 1% 1% 0.5% 0.5% 1% 1%
Dosage form(s) OINTMENT OINTMENT
Route of administration RECTAL RECTAL RECTAL RECTAL
Packaging size 30g OIN CA 30g OIN CA
ATC code C05AA C05AA
ATC description AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-03-26 2021-03-26
Estimated end date Unknown Unknown
Actual end date 2021-08-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments product discontinued
Health Canada comments